- Home
- ATRA vs FGNX Comparison
ATRA vs FGNX Comparison
Compare ATRA & FGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATRA | FGNX |
|---|---|---|
| Founded | 2012 | 1932 |
| Country | United States | United States |
| Employees | N/A | 15 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.9M | 44.1M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | ATRA | FGNX |
|---|---|---|
| Price | $10.51 | $8.57 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $5.00 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 3.2M | 166.3K |
| Earning Date | 05-13-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 122.52 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $120,772,000.00 | N/A |
| Revenue This Year | N/A | $650.31 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.92 | $1.59 |
| 52 Week High | $19.15 | $18.42 |
Technical Indicators
Market Signals| Indicator | ATRA | FGNX |
|---|---|---|
| Relative Strength Index (RSI) | 64.28 | 70.16 |
| Support Level | $4.35 | $5.68 |
| Resistance Level | $12.91 | $9.35 |
| Average True Range (ATR) | 1.07 | 0.79 |
| MACD | 0.08 | 0.17 |
| Stochastic Oscillator | 72.03 | 94.41 |
Price Performance
Historical ComparisonAbout ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
About FGNX Fundamental Global Inc.
FG Nexus Inc operates through two primary segments: Digital Assets and Merchant Banking, with Digital Assets contributing the majority of revenue. The Company functions as a digital asset treasury, mainly holding Ethereum (ETH) and exploring opportunities in the tokenization of real-world assets, leveraging ETH as the foundation for digital finance, stablecoins, DeFi, and tokenized assets. The Merchant Banking segment offers strategic, administrative, and regulatory support to newly formed SPACs through the Company's SPAC platform.